Loading
Latest filing published 05 Sept 2025 for Utah Medical Products INC, €2,692.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Brian Koopman (finance chief) discloses dealings in Utah Medical Products Inc to SEC (Form 4). In total, 10 filings cover trades dated from 5 November 2019 to 4 September 2025.
Sales make up the whole of the open-market record (1 sale, €29k). Besides market trades, the filings include 2 share grants and 3 option exercises.
The record was last updated on 5 September 2025 with a transaction (€2,692) in Utah Medical Products Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations